Company: VCYT
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001384101-25-000130
Chunk: 13

Company: VERACYTE, INC.
Filing Date: 2025-11-05
Form: 10-Q
Item: Part I, Item 1
Chunk 13
---
Item 1. Condensed Consolidated Financial Statements-(Unaudited)

VERACYTE, INC. 

Condensed Consolidated Balance Sheets 

(unaudited)

(In thousands, except share and par value amounts)

 September 30, 2025December 31, 2024  Assets  Current assets:  Cash and cash equivalents$315,573 $239,087 Short-term investments50,855 50,354 Accounts receivable47,826 46,525 Supplies and inventory20,327 21,750 Prepaid expenses and other current assets14,643 14,551 Total current assets449,224 372,267 Property, plant and equipment, net18,900 22,953 Right-of-use assets, operating leases37,301 48,189 Intangible assets, net92,477 102,301 Goodwill767,154 745,800 Restricted cash1,637 1,544 Other assets1,094 6,981 Total assets$1,367,787 $1,300,035 Liabilities and Stockholders’ EquityCurrent liabilities:Accounts payable$5,509 $8,634 Accrued liabilities48,373 43,826 Current portion of deferred revenue417 1,673 Current portion of acquisition-related contingent consideration13,571 16,981 Current portion of operating lease liabilities4,282 7,500 Current portion of other liabilities— 19 Total current liabilities72,152 78,633 Deferred tax liabilities1,214 1,227 Acquisition-related contingent consideration, net of current portion583 561 Operating lease liabilities, net of current portion36,171 43,237 Other liabilities— 411 Total liabilities110,120 124,069 Commitments and contingenciesStockholders’ equity:Preferred stock, $0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of September 30, 2025 and December 31, 2024— — Common stock, $0.001 par value; 125,000,000 shares authorized, 79,034,078 and 77,772,678 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively79 78 Additional paid-in capital1,684,587 1,655